Effect of Music and Warm Foot Bath Therapy on Pregnancy-Related Anxiety, Blood Pressure and Quality of Life
Launched by KIRKLARELI UNIVERSITY · Jul 11, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how listening to music and taking warm foot baths might help reduce anxiety related to pregnancy, lower blood pressure, and improve overall quality of life for women who are pregnant for the first time. The study involves four groups: one listens to music, one takes warm foot baths, one does both, and one group receives no treatment. These activities will last for two weeks, and researchers will measure anxiety and quality of life before and after to see if there are any improvements.
Women who are between 18 and 39 years old, pregnant with a single, healthy baby at 26 weeks or later, and considered low-risk are eligible to participate. They also need to be able to read and communicate well, and have a smartphone. Women with certain medical conditions, pregnancy complications, or hearing problems, as well as those who are pregnant with multiples or have had fertility treatments, will not be included. If you join the study, you’ll be randomly assigned to one of the groups and asked to follow the therapy for two weeks while the researchers track how you feel and your blood pressure. This study aims to find easy and relaxing ways to support pregnant women’s well-being during this important time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18-39 years of age,
- • Literate; able to make an informed decision to participate, communicate verbally, and sign a consent form
- • Pregnant with a single, live fetus
- • Have a smartphone
- • Low-risk primigravida pregnant with a gestational age of 26 weeks or more
- Exclusion Criteria:
- • - Having hearing impairment,
- • Refusing to participate,
- • Being illiterate,
- • Having communication problems,
- • Being hospitalized with severe preeclampsia,
- • The newborn not surviving.
- • Antepartum hemorrhage
- • Preeclampsia,
- • Gestational hypertension,
- • Cervical insufficiency,
- • Having pregnancy-related complications such as congenital fetal anomalies and intrauterine growth restriction diagnosed before 28 weeks of gestation or having multiple pregnancies;
- • Having psychiatric disorders (known anxiety or depression, other illnesses),
- • Having medical problems such as endocrine disorders (gestational diabetes mellitus, thyroid dysfunction, etc.);
- • Having assisted reproductive techniques (ART) such as in vitro fertilization, embryo transfer, or
- • Pregnant women at risk of preterm birth will not be included in the study.
About Kırklareli University
Kırklareli University is a distinguished academic institution dedicated to advancing medical research and clinical innovation. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that leverage cutting-edge methodologies and interdisciplinary collaboration. Its research programs are designed to address pressing medical challenges, fostering an environment that encourages rigorous scientific inquiry and ethical practices. By engaging with local and international partners, Kırklareli University aims to contribute significantly to the advancement of medical knowledge and the development of effective therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edirne, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported